CONTEXT: Tracheobronchomalacia (TBM) results from structural and functional abnormalities of the respiratory system. It is characterized by excessive collapse: at least 50% of the cross-sectional area of the trachea and main bronchi. In this paper, we present a rare case of a patient with TBM who first presented with stridor and respiratory failure due to exacerbation of chronic bronchitis. CASE REPORT: An 81-year-old Caucasian man was admitted presenting coughing, purulent sputum, stridor and respiratory failure. He had a medical history of chronic obstructive pulmonary disease (COPD) and silicosis and was a former smoker. Axial computed tomography on the chest revealed marked collapse of the trachea in its middle third. Bronchoscopy showed characteristics compatible with TBM. He was treated with noninvasive ventilation, without any good response. Subsequently, a Dumon Y stent was placed by means of rigid bronchoscopy. After the procedure, he was discharged with a clinical improvement. CONCLUSION: TBM is fatal and often underdiagnosed. In COPD patients, stridor and respiratory failure may be helpful signs that should alert physicians to consider TBM as an early diagnosis. Thus, these signs may be important for optimizing the treatment and evolution of such patients.
INTRODUCTION
Tracheobronchomalacia (TBM) is a disease of the central airways in which tissue fragility develops in the trachea due to destruction of the supporting cartilage, thereby leading to structural and functional instability of the respiratory system. 1 TBM is characterized by excessive collapse, consisting of at least 50% of the cross-sectional area of the trachea and the main bronchial lumen, in association with increased compliance of the airway wall, supporting cartilaginous rings, or both. 2 Histopathological studies on patients with TBM have shown inflammatory infiltrates with T lymphocytes and macrophages. 1 The incidence of TBM accounts for about 1% of all patients undergoing bronchoscopy. 3 We present a rare case of a patient with TBM who first presented with stridor and respiratory failure due to exacerbation of bronchitis. We focus on the diagnostic difficulties and present a literature review. 10-50) and plasma creatinine of 2.5 mg/dl (reference value: 0.6- 
CASE REPORT

DISCUSSION
To our knowledge, the first case of TBM was described by Czyhlarz et al. 4 at the end of the 19 th century. Some decades later, in 1949, Lemoine et al. 5 were the first to describe acquired tracheal enlargement in adults, by means of bronchoscopy. In 1952, TBM was described by Holinger et al. as tracheal flaccidity and collapse during the expiratory phase of respiration, based on a bronchoscopy study on three patients presenting with stridor, cyanosis and obstruction. 6 The clinical symptoms normally include dyspnea, chronic coughing and recurrent respiratory infections. 7 In the present report, the patient presented stridor that was treated with CPAP.
According to Carden et al., 8 TBM is classified into primary (genetic or idiopathic) and secondary, such as post-traumatic, emphysema/COPD, chronic infection/bronchitis, chronic Advances in imaging assessments using computed tomography (CT) and interventional bronchoscopy have improved the recognition of TBM and the clinical approach towards it. 3 Traditionally, bronchoscopy has been the gold standard examination for diagnosing TBM. 2 However, recently, the use of paired multidetector inspiratory-dynamic expiratory computed tomography (MDCT) has been shown to be an effective, noninvasive examination for diagnosing TBM. 15 Conventional CT scan techniques allow radiologists to make a diagnosis of fixedairway narrowing, but only MDCT enables a diagnosis of TBM, through demonstrating excessive expiratory collapse of the airways throughout the respiratory cycle. 16 In the present case, the chest CT initially suggested airway collapse, probably because the patient was not collaborative during the scan inspiration, and an expiratory image was obtained instead. The bronchoscopy was thus decisive for the diagnosis and for addressing the respiratory failure and stridor when the Dumon Y stent was emplaced.
There is no consensus regarding treatments for TBM. 1 Identifying patients with symptoms and severe disease is still a challenge. The possible approaches are pharmacological treatment, such as treatments for COPD and GERD, noninvasive ventilation using CPAP, stents (silicon, metal or hybrid) and surgery, 
